GRAFT-VERSUS-HOST DISEASE (GVHD)
Clinical trials for GRAFT-VERSUS-HOST DISEASE (GVHD) explained in plain language.
Never miss a new study
Get alerted when new GRAFT-VERSUS-HOST DISEASE (GVHD) trials appear
Sign up with your email to follow new studies for GRAFT-VERSUS-HOST DISEASE (GVHD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race to stop transplant rejection: two drug cocktails face off in major trial
Disease control Recruiting nowThis study compares two different combinations of medications given after a stem cell transplant to prevent graft-versus-host disease (GVHD), where donor cells attack the patient's body. Researchers want to see which drug combination better helps patients survive without developi…
Matched conditions: GRAFT-VERSUS-HOST DISEASE (GVHD)
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Gentler transplant drug could boost recovery for older cancer patients
Disease control Recruiting nowThis study is for older adults getting a stem cell transplant for blood cancers. It compares two different doses of a key drug (cyclophosphamide) used to prevent a serious complication called graft-versus-host disease (GVHD). The main goal is to see if a lower dose helps patients…
Matched conditions: GRAFT-VERSUS-HOST DISEASE (GVHD)
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC